Jeffrey Rothstein

Ten leaders in the field of ALS research put their heads together on Oct. 24, 2009

posted on October 30, 2009 - 5:18pm
  An all-day "think tank" to consider priorities for amyotrophic lateral sclerosis (ALS) research based on the latest information was conducted with ten of the leading scientists and clinicians in the field and senior MDA staff in Tucson, Ariz., on Saturday, Oct. 24, 2009. Each specialist introduced his or her area of expertise and led an approximately 20-minute discussion, gathering input...

When ALS-affected nerve cells lose function, their closest neighbors can't protect them

posted on May 8, 2009 - 11:45am
A vicious cycle in which damage to nerve cells (neurons) in the spinal cord results in the loss of an important mechanism to protect neurons, causing more neuron loss, has been identified as a possible contributor to ALS (amyotrophic lateral sclerosis). Identification of this pathway opens the door to targeting it with therapeutic agents.